Anti-cerebralischemia APIs

Cerebral ischemia is a common cerebrovascular disease, and its treatment goals are to restore brain blood flow as soon as possible, reduce brain tissue damage, and prevent recurrence. At Protheragen, our anti-cerebral ischemia APIs effectively protect brain tissue from ischemia-reperfusion injury through multiple mechanisms such as improving brain microcirculation, inhibiting platelet aggregation, reducing oxidative stress and neuroinflammation.

Protheragen offers a full range of anti-cerebral ischemia APIs to support our customers' research worldwide.

Cat Product Name Cas Details Chemical Structure
API6066495 3-butylphthalide 6066-49-5 View Details APIs
Inquiry

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top